ICUI Stock — ICU Medical, Inc.

ICU Medical, Inc. (ICUI)

Updated October 16, 2026.

ICUI is a Stock. Total return is 3603.1% over the past 34.5 years.

ICU Medical develops, manufactures, and sells medical devices for infusion therapy, vascular access, and vital care applications, including needlefree connectors, infusion pumps, IV solutions, hemodynamic monitoring products, and anesthesia systems used by hospitals, clinics, and home care providers worldwide. The company does not currently have an established regular distribution schedule. This business appeals to healthcare-focused investors seeking exposure to medical device manufacturing.

ICUI performance

Price and return data through 2026-10-16.

Total return is 3603.1% over the past 34.5 years. Over the past year its total return — price change plus distributions reinvested — is 39.9%. Its deepest 1-year drawdown was 27.2%.

ICUI key facts

Asset type

Stock

Asset class

Equity

Inception date

03/31/1992

Distribution frequency

None

Last close

$162.99 (as of 2026-10-16)

Market cap

$4,075,897,124

Average volume

221673.0

Dividend

$2.25

Beta

0.865

Payout ratio

0.0%

P/E ratio

138.13

Forward P/E

16.9492

EPS

$1.18

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ICUI risks and drawbacks

The deepest 1-year drawdown on record here is 27.2%.

Who may consider ICUI — and who may not

It is a weaker fit for investors who need monthly cash flow (ICUI does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on ICUI

• All tickers starting with I

Tagged: Healthcare.

Frequently asked questions